DK157733C - Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof - Google Patents
Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstofInfo
- Publication number
- DK157733C DK157733C DK593083A DK593083A DK157733C DK 157733 C DK157733 C DK 157733C DK 593083 A DK593083 A DK 593083A DK 593083 A DK593083 A DK 593083A DK 157733 C DK157733 C DK 157733C
- Authority
- DK
- Denmark
- Prior art keywords
- tracer
- sup
- binding agent
- units
- excipients
- Prior art date
Links
- 230000002285 radioactive effect Effects 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 239000000700 radioactive tracer Substances 0.000 abstract 10
- 239000011230 binding agent Substances 0.000 abstract 7
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 238000002386 leaching Methods 0.000 abstract 2
- 238000009792 diffusion process Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000030136 gastric emptying Effects 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Farming Of Fish And Shellfish (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK593083A DK157733C (da) | 1982-04-23 | 1983-12-22 | Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK183982 | 1982-04-23 | ||
| DK183982 | 1982-04-23 | ||
| PCT/DK1983/000047 WO1983003762A1 (en) | 1982-04-23 | 1983-04-22 | Composition and method for investigating alimentary functions |
| DK8300047 | 1983-04-22 | ||
| DK593083 | 1983-12-22 | ||
| DK593083A DK157733C (da) | 1982-04-23 | 1983-12-22 | Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK593083A DK593083A (da) | 1983-12-22 |
| DK593083D0 DK593083D0 (da) | 1983-12-22 |
| DK157733B DK157733B (da) | 1990-02-12 |
| DK157733C true DK157733C (da) | 1990-07-16 |
Family
ID=8108447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK593083A DK157733C (da) | 1982-04-23 | 1983-12-22 | Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4657755A (da) |
| EP (1) | EP0092993B1 (da) |
| JP (1) | JPS59500614A (da) |
| AT (1) | ATE40949T1 (da) |
| CA (1) | CA1222947A (da) |
| DE (2) | DE3379256D1 (da) |
| DK (1) | DK157733C (da) |
| FI (1) | FI834776A7 (da) |
| NO (1) | NO834780L (da) |
| NZ (1) | NZ204009A (da) |
| WO (1) | WO1983003762A1 (da) |
| ZA (1) | ZA832904B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5165410A (en) | 1987-05-15 | 1992-11-24 | Medical & Scientific Enterprises, Inc. | Position indicating system for a multidiagnostic scanner |
| US5261406A (en) * | 1991-01-15 | 1993-11-16 | Medasys Inc. | Whole body imaging system |
| US5407659A (en) * | 1991-10-22 | 1995-04-18 | Mallinckrodt Medical, Inc. | Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
| US5342609A (en) * | 1991-10-22 | 1994-08-30 | Mallinckrodt Medical, Inc. | Microfluidization of calcium/oxyanion-containing particles |
| US5344640A (en) * | 1991-10-22 | 1994-09-06 | Mallinckrodt Medical, Inc. | Preparation of apatite particles for medical diagnostic imaging |
| US5350584A (en) * | 1992-06-26 | 1994-09-27 | Merck & Co., Inc. | Spheronization process using charged resins |
| US5520904A (en) * | 1995-01-27 | 1996-05-28 | Mallinckrodt Medical, Inc. | Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging |
| US5827497A (en) * | 1996-08-14 | 1998-10-27 | Mayo Foundation For Medical Education And Research | Charcoal-radionuclide agents for measurement of gastrointestinal transit |
| US20060073202A1 (en) * | 2004-10-05 | 2006-04-06 | Rocca Jose G | Dual component medicament delivery system |
| AU2007275251A1 (en) * | 2006-07-19 | 2008-01-24 | Smithkline Beecham Corporation | Method for radiolabeling formulations for gamma scintigraphy assessment |
| US10299745B2 (en) | 2014-12-29 | 2019-05-28 | Loyola University Of Chicago | Traceable devices for gastrointestinal use and methods of use and manufacturing the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2611730A (en) * | 1950-09-02 | 1952-09-23 | Simth Kline & French Lab | Medical preparation for reducing the body level of sodium |
| DK106457C (da) * | 1962-01-23 | 1967-02-06 | Ernst Helmer Hagstam | Røntgenkontrastmiddel med lille massefylde og fremgangsmåde til dets fremstilling. |
| NL7017227A (da) * | 1969-12-27 | 1971-06-29 | ||
| US4115540A (en) * | 1976-06-16 | 1978-09-19 | The University Of Kentucky Research Foundation | Radiodiagnostic agent |
| US4107283A (en) * | 1976-07-19 | 1978-08-15 | New England Nuclear Corporation | Tracer for circulation determinations |
| GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
| US4243652A (en) * | 1978-07-14 | 1981-01-06 | The Procter & Gamble Company | Gastrointestinal scanning agent |
| GB2057420B (en) * | 1979-08-30 | 1984-05-10 | Standard Telephones Cables Ltd | Controlled release glass |
-
1983
- 1983-04-22 DE DE8383302304T patent/DE3379256D1/de not_active Expired
- 1983-04-22 US US06/568,184 patent/US4657755A/en not_active Expired - Fee Related
- 1983-04-22 AT AT83302304T patent/ATE40949T1/de not_active IP Right Cessation
- 1983-04-22 JP JP58501422A patent/JPS59500614A/ja active Granted
- 1983-04-22 EP EP83302304A patent/EP0092993B1/en not_active Expired
- 1983-04-22 WO PCT/DK1983/000047 patent/WO1983003762A1/en not_active Ceased
- 1983-04-22 CA CA000426523A patent/CA1222947A/en not_active Expired
- 1983-04-22 DE DE198383302304T patent/DE92993T1/de active Pending
- 1983-04-25 ZA ZA832904A patent/ZA832904B/xx unknown
- 1983-04-26 NZ NZ204009A patent/NZ204009A/en unknown
- 1983-12-22 NO NO834780A patent/NO834780L/no unknown
- 1983-12-22 DK DK593083A patent/DK157733C/da not_active IP Right Cessation
- 1983-12-23 FI FI834776A patent/FI834776A7/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0092993B1 (en) | 1989-03-01 |
| DK157733B (da) | 1990-02-12 |
| ATE40949T1 (de) | 1989-03-15 |
| JPS59500614A (ja) | 1984-04-12 |
| EP0092993A2 (en) | 1983-11-02 |
| DK593083A (da) | 1983-12-22 |
| DE3379256D1 (en) | 1989-04-06 |
| JPS6222971B2 (da) | 1987-05-20 |
| WO1983003762A1 (en) | 1983-11-10 |
| NZ204009A (en) | 1986-03-14 |
| FI834776A0 (fi) | 1983-12-23 |
| FI834776A7 (fi) | 1983-12-23 |
| NO834780L (no) | 1983-12-22 |
| US4657755A (en) | 1987-04-14 |
| EP0092993A3 (en) | 1984-07-18 |
| DE92993T1 (de) | 1984-03-29 |
| ZA832904B (en) | 1984-01-25 |
| DK593083D0 (da) | 1983-12-22 |
| CA1222947A (en) | 1987-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lindgren et al. | Autoradiographic studies on the distribution of arsenic in mice and hamsters administered 74As‐arsenite or‐arsenate | |
| DK157733C (da) | Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof | |
| DE3065420D1 (en) | Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours | |
| Norman et al. | Studies on film thickness, solubility, and marginal leakage of dental cements | |
| DK154263C (da) | Fremgangsmaade til fremstilling af et farmaceutisk indoraminpraeparat med langvarig frigivelse og indeholdende et vandkanaldannelsesmiddel | |
| Speck et al. | Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB) | |
| Larson et al. | Positron imaging feasibility studies. I: Characteristics of [3H] thymidine uptake in rodent and canine neoplasms: concise communication | |
| DE2124752A1 (de) | Verfahren zur Herstellung eines diagnostischen Präparats auf Basis von Makroaggregaten von mit 99mTc markiertem Serumeiweiß | |
| Nayak et al. | A comparison of high-versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro | |
| US4042677A (en) | Technetium-99m labeled radiodiagnostic agents and method of preparation | |
| JPS5750928A (en) | Diagnostic agent for scanning bone | |
| IT8268020A0 (it) | Derivati carbostirilici procedimento per la loro preparazione e composizioni cardiotoniche contenenti tali derivati | |
| Marshall et al. | Adenomas of the human parathyroid. Light and electron microscopic study following selenium 75 methionine scan | |
| JPS585887B2 (ja) | ホウシヤセイイヤクヒン オヨビソノ セイゾウホウホウ | |
| Takeda | Comparative metabolism of tritium in rat after single ingestion of some tritiated organic compounds versus tritiated water | |
| GB1502441A (en) | Biologically-active materials | |
| Foreman | The effect of diethylenetriaminepentaacetic acid (DTPA) on acceleration of excretion of actinide elements | |
| Vaira et al. | Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases | |
| JPS5244682A (en) | Direct reading type ray absorbed dose rate measuring apparatus | |
| Ogiński et al. | 99mTechnetium-Unithiol complex, a new pharmaceutical for kidney scintigraphy | |
| JPS56123912A (en) | Drug-containing tape preparation | |
| Wai et al. | Formulation and pharmacological studies of a controlled release pentagastrin injection | |
| Green et al. | The distribution of plutonium in the mouse ovary | |
| JPS5677209A (en) | Iodophor composition | |
| Ballinger et al. | Stabilization of 99mTc-pyrophosphate injection with gentisic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |